Palliare completes USD8m Series A funding round
Palliare has closed an oversubscribed USD8 million Series A funding round led by leading European Life Sciences Venture Capital firm Seroba Life Sciences, with participation from Luxembourg-based SCM AD Ventures, Western Development Commission, and several private investors. The funds will be used to support US commercial launch activities related to